PubMed · 11155585
Systemic antifungal therapy.
Abstract
Systemic antifungal therapy for superficial mycoses has advanced greatly since the introduction of griseofulvin in 1958. The discovery of the azole antifungal compounds, ketoconazole, itraconazole, and fluconazole, allowed for a broader spectrum of treatment and a shorter treatment duration. Terbinafine, through a unique mechanism of action, has a fungicidal power not seen previously in the other antifungals. It is important to use our knowledge of the pharmacology in combination with clinical experience and cost of therapy in order to select the proper drug. The search to identify new oral antifungal agents should continue, since none of the five currently used drugs fulfill the criteria of the "ideal" antifungal.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
M Moossavi, B Bagheri, R K Scher. 2001. Systemic antifungal therapy.. https://doi.org/10.1016/s0733-8635(05)70228-x. https://pubmed.health/record/pubmed%3A11155585/systemic-antifungal-therapy
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.